Bioavailability Study of Magne-B6 New Formulation

Clinical trial NCT06386211 · COMPLETED

Trial details

NCT number: NCT06386211
Sponsor: Opella Healthcare Group SAS, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-07-03
Primary completion: 2024-08-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.